Information date: 28 October 2026 — High-tech enterprise (HNTE) status is a tax designation: corporate income tax falls from 25% to 15%. The R&D-intensity test is banded at 5% of sales below RMB 50 million, 4% between RMB 50 and 200 million and 3% above, with domestic R&D at least 60% of the total, technical staff at least 10% of headcount and high-tech product revenue at least 60% of total revenue. 'Little giant' status is a Ministry of Industry and Information Technology list, not a tax rate: it screens R&D ratio, patents, niche market position and unlocks provincial cash awards and bank credit windows. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
High-tech enterprise (HNTE) status is a tax designation: corporate income tax falls from 25% to 15%. The R&D-intensity test is banded at 5% of sales below RMB 50 million, 4% between RMB 50 and 200 million and 3% above, with domestic R&D at least 60% of the total, technical staff at least 10% of headcount and high-tech product revenue at least 60% of total revenue. 'Little giant' status is a Ministry of Industry and Information Technology list, not a tax rate: it screens R&D ratio, patents, niche market position and unlocks provincial cash awards and bank credit windows.
Relevant to foreign-invested manufacturers and technology companies with a China legal entity choosing between the two designations. Confirm first: prior-year sales revenue, the R&D expense pooling scope (personnel, direct input, depreciation, design fees), the domestic R&D share, time records for technical staff, whether IP is owned by the China entity rather than the offshore parent, and the local subsidy package each designation triggers in the province of registration.
How the effect reaches operations
These are two different policy instruments. HNTE is jointly recognised by science, finance and tax authorities, and its output changes the CIT rate directly. Little giant is an industrial-chain screening run by the industry ministry, used for financing, special fiscal funds and procurement scoring. R&D intensity is only the entry ticket: HNTE tests accounting consistency between the R&D auxiliary ledger, the special audit and the tax return, while little giant tests niche market share, patent count and the lead product.
Frequent misjudgements: applying the HNTE R&D ratio to a little giant filing; pooling R&D differently in the auxiliary ledger, the audit report and the CIT return, which triggers clawback after recognition; IP held by the offshore parent so the China entity cannot count it; and treating the little giant label as a tax benefit, leaving no budget for the 25% rate.
For “Comparison: China's National High-Tech Enterprise Status vs 'Little Giant' SME Certification — R&D-Intensity Tests, Scoring Dossiers and the CIT Rate Each Unlocks”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
If the objective is lowering income tax, prioritise HNTE: build a three-year plan around the R&D ledger, onshore IP ownership and high-tech revenue mix, since 15% versus 25% is worth roughly one point of sales each year. Add the little giant filing only when financing, local government support or supply-chain credibility is the goal, and never model it as a tax outcome. Where the R&D definitions differ, keep two separate ledgers.
Implementation checklist
- Map last year's R&D spend against the 5/4/3% revenue bands before choosing a route.
- Confirm that core IP is registered to the China entity, not the offshore parent.
- Keep the R&D auxiliary ledger, audit report and CIT return on one identical scope.
- Assign one decision owner, one implementation owner and a dated review point for “Comparison: China's National High-Tech Enterprise Status vs 'Little Giant' SME Certification — R&D-Intensity Tests, Scoring Dossiers and the CIT Rate Each Unlocks”.
- For “Comparison: China's National High-Tech Enterprise Status vs 'Little Giant' SME Certification — R&D-Intensity Tests, Scoring Dossiers and the CIT Rate Each Unlocks”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “Comparison: China's National High-Tech Enterprise Status vs 'Little Giant' SME Certification — R&D-Intensity Tests, Scoring Dossiers and the CIT Rate Each Unlocks”.
Evidence and review
For “Comparison: China's National High-Tech Enterprise Status vs 'Little Giant' SME Certification — R&D-Intensity Tests, Scoring Dossiers and the CIT Rate Each Unlocks”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Map last year's R&D spend against the 5/4/3% revenue bands before choosing a route.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Confirm that core IP is registered to the China entity, not the offshore parent.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Keep the R&D auxiliary ledger, audit report and CIT return on one identical scope.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
A comparison of two recognition regimes, not tax, accounting or legal advice; eligibility depends on the entity's accounts, IP ownership and local rules and must be verified with a licensed adviser.
